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Purpose: To describe the features of peripapillary pachychoroid syndrome (PPS),
a novel pachychoroid disease spectrum (PDS) entity.
Methods: Medical records of 31 eyes (16 patients) with choroidal thickening associated
with intraretinal and/or subretinal ﬂuid in the nasal macula extending from the disk were
reviewed (patients with PPS). Choroidal thickness was compared with 2 age-matched
cohorts: typical PDS (17 eyes with central serous chorioretinopathy or pachychoroid
neovasculopathy) and 19 normal eyes.
Results: The patients with PPSwere 81%men aged 71 ± 7 years. Peripapillary pachychoroid
syndrome eyes displayed thicker nasal versus temporal macular choroids, unlike PDS eyes with
thicker temporal macular choroids (P , 0.0001). Peripapillary intraretinal and/or subretinal ﬂuid
was often overlying dilated Haller layer vessels (pachyvessels). Fundus autoﬂuorescence and
ﬂuorescein angiography illustrated peripapillary pigmentary mottling without focal leakage. Most
PPS eyes (70%) exhibited other PDS ﬁndings including serous pigment epithelial detachment or
gravitational tracks. Indocyanine green angiography illustrated dilated peripapillary pachyvessels
and choroidal hyperpermeability. The disk was usually crowded, with edema noted in 4/31 (13%)
eyes and mild late ﬂuorescein disk leakage identiﬁed in half of the cases. Choroidal folds (77%),
short axial lengths (39% less than 23 mm), and hyperopia (86%) were common.
Conclusion: Peripapillary pachychoroid syndrome is a distinct PDS variant, in which
peripapillary choroidal thickening is associated with nasal macular intraretinal and/or subretinal
ﬂuid and occasional disk edema. Recognition of PPS is important to distinguish it from disorders
with overlapping features such as posterior uveitis and neuro-ophthalmologic conditions.
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The pachychoroid disease spectrum (PDS) refers toa group of retinochoroidal disorders that share dis-
tinctive choroidal ﬁndings identiﬁed with multimodal
retinal imaging. These choroidal features include focal
or diffuse choroidal thickening associated with reduced
fundus tessellation, dilated Haller layer vessels (termed
“pachyvessels”) with thinning of the overlying inner
choroid, and choroidal hyperpermeability demonstrated
with indocyanine green angiography (ICGA). The PDS
includes pachychoroid pigment epitheliopathy,1 focal
choroidal excavation,2 central serous chorioretinopathy
(CSC),3 pachychoroid neovasculopathy,4 and polypoi-
dal choroidal vasculopathy.5
We have identiﬁed a novel PDS variant, in which
pachychoroid features surround the optic nerve and are
associated with intraretinal and/or subretinal ﬂuid and
optic nerve head edema in some eyes. Associated
ﬁndings including serous pigment epithelial detach-
ment, choroidal hyperpermeability, and pachyvessels
suggest that this is a pachychoroid-driven entity, rather
than a variant of uveal effusion syndrome (UES) as was
suggested in a single-case report.6 As such, we propose
the term “peripapillary pachychoroid syndrome” (PPS).
The aim of this investigation is to report the features of
this syndrome and to compare this disorder with both
normal eyes and two typical PDS entities, CSC, and
pachychoroid neovasculopathy.
Methods
Subjects
This retrospective, multicenter, observational case
series was approved by the University of California Los
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Angeles Institutional Review Board. The study adhered
to the tenets of the Declaration of Helsinki and was
conducted in accordance with the Health Insurance
Portability and Accountability Act (HIPAA) regulations.
Patients with peripapillary choroidal thickening and
intraretinal and/or subretinal ﬂuid in the nasal macular
region extending from the temporal margin of the optic
disk as noted with optical coherence tomography (OCT)
were identiﬁed and comprised Group 1. Peripapillary
choroidal thickening was deﬁned by the presence of 1)
a thicker choroid than would be expected for age and/or
2) choroidal thickening associated with Haller vessel
dilation and overlying inner choroidal thinning.1,3,4 Pa-
tients were excluded from this group if they demonstrated
other causes of macular edema, unrelated to a PDS entity,
including any evidence of ocular inﬂammation, macular
edema due to diabetic macular edema or retinal vascular
occlusion, radiation retinopathy, signiﬁcant epiretinal
membrane formation, any history of intraocular surgery
within the past 6 months before presentation, or the use of
medications known to be associated with cystoid macular
edema. Eyes with clinical or imaging evidence of choroi-
dal neovascularization were excluded from this cohort.
Patients with cavitary optic disk anomalies (e.g., optic disk
pit, optic disk coloboma), optic atrophy, glaucomatous
optic neuropathy, or ocular tumors were also excluded.
Medical records and multimodal imaging ﬁndings
were comprehensively reviewed. The data collected
included age, sex, medical history, Snellen visual
acuity, axial length and refraction, and the ﬁndings of
complete ocular examination. Multimodal imaging
included color fundus photography (Carl Zeiss Meditec,
Dublin, CA; Topcon Medical Systems, Oakland, NJ;
Optos, Dunfermline, Scotland), spectral domain OCT
(SPECTRALIS; Heidelberg Engineering, Heidelberg,
Germany), enhanced depth imaging OCT (EDI-OCT)
(SPECTRALIS, Heidelberg Engineering), swept-source
OCT (DRI OCT Triton, Topcon Medical Systems),
ﬂuorescein angiography (FA) (Carl Zeiss Meditec;
SPECTRALIS, Heidelberg Engineering; Topcon Med-
ical Systems; Optos), ICGA (SPECTRALIS; Heidel-
berg Engineering), and fundus autoﬂuorescence (FAF)
(SPECTRALIS, Heidelberg Engineering; Optos).
Eleven consecutive patients (17 eyes) older than or
equal to 50 years with typical ﬁndings of CSC or
pachychoroid neovasculopathy (i.e., patients with typ-
ical ﬁndings of PDS) were recruited from the practice of
D.S. as a comparative control group and comprised
Group 2. Central serous chorioretinopathy was deﬁned
by the presence of choroidal thickening within the
macula associated with subretinal ﬂuid and correspond-
ing leakage on FA or macular retinal pigment epithe-
lium (RPE) abnormalities with granular
autoﬂuorescence and gravitational tracks. Patients with
CSC or pachychoroid features associated with shallow
irregular RPE detachment harboring Type 1 neovascu-
larization (pachychoroid neovasculopathy) were also
included in Group 2. In addition, 19 age-matched
normal eyes from 12 patients with no ocular disease
other than early cataract, or a history of cataract surgery
were included as normal control eyes (Group 3).
Image Analysis
Choroidal thickness measurement. Choroidal thick-
ness measurements were performed using EDI-OCT
images, and the caliper tool provided with the review
software (Heidelberg Eye Explorer, v1.9.10.0 soft-
ware; Heidelberg Engineering). Choroidal thickness
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was deﬁned as the perpendicular distance between
Bruch membrane and the choroidal scleral junction.
The measurement was performed on a horizontal
section passing through the central fovea at the
following positions: 1) the center of the fovea (sub-
foveal), 2) 1,500 mm nasal to the foveal center (N1.5),
3) 3,000 mm nasal to the foveal center (N3.0), 4) 1,500
mm temporal to the foveal center (T1.5), 5) 3,000 mm
temporal to the foveal center (T3.0), and 6) 250 mm
temporal to Bruch membrane origin at the temporal
disk margin (BMO250) (Figure 1A). Images were
set to an aspect ratio of 1:1 mm before each measure-
ment. The hyporeﬂective band corresponding to the
suprachoroidal space when present was not included
in the choroidal thickness measurement.7 If the cho-
roidal scleral junction was not clearly identiﬁed,
brightness and contrast of the image was adjusted,
using the built-in adjustment tool, to best visualize this
junction, and the outer choroidal border was identiﬁed
by the line connecting the outer margin of the large
choroidal vessel layer. When available, adjacent EDI-
OCT scans were reviewed to conﬁrm the accuracy of
identifying the choroidal scleral junction. In one
patient, choroidal thickness was measured on swept-
source OCT images using Image J 1.51a software8
with appropriate scales.
Two independent trained graders (N.P. and M.A.)
performed all the measurements. Large disagree-
ments (.100 mm) over readings were resolved by
open adjudication between the readers (2 instances).
Fig. 1. Enhanced depth imag-
ing OCT of the macula and
choroid. A. Positions of choroi-
dal thickness measurement used
in this study. BMO250, 250 mm
temporal to Bruch membrane
origin at the temporal disk
margin; N1.5, 1,500 mm nasal to
the foveal center; N3.0, 3,000
mm nasal to the foveal center;
SF, subfoveal; T1.5, 1,500 mm
temporal to the foveal center;
and T3.0, 3,000 mm temporal to
the foveal center. B. Normal left
eye of a 71-year-old woman. C.
Left eye of a 69-year-old man
with typical chronic CSC. D.
Left eye of a 75-year-old man
with PPS. Note the peripapillary
intraretinal cysts (arrow) and dis-
proportionate thickening of the
nasal choroid associated with
choroidal folds in (D) versus the
tapering nasal choroid in (B and
C). Furthermore, there are more
dilated large choroidal vessels
(pachyvessels) on the nasal side
compared with the temporal side
in (D). White asterisks denote
pachyvessels with associated
thinning of the overlying inner
choroid. Choroidal thickness is
outlined with arrowheads.
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Measurements from the main reader (N.P.) were used
for the analysis, whereas those from the second
reader (M.A.) were only used to calculate intergrader
agreement.
Juxtapapillary retinal structures. For Group 1,
retinal structures at the temporal disk margin included
in the macula OCT scans were evaluated for the
presence of intraretinal ﬂuid, subretinal ﬂuid and
Fig. 2. Multimodal imaging of a 63-year-old man with PPS. A and B. Fundus autoﬂuorescence illustrates hypoautoﬂuorescent peripapillary atrophy
(PPA) and large areas of peripapillary mottled autoﬂuorescence in both eyes. Hyperautoﬂuorescent patches are illustrated superotemporal in the left eye
and inferior in both eyes and correspond to outer retinal atrophy similar to chronic CSC. C and D. Late-phase FA illustrates speckled hyperﬂuorescent
window defects and staining surrounding the optic disk and intense staining of PPA in both eyes. There is no distinct leakage. E and F. Early-phase
ICGA illustrates peripapillary dilated large choroidal vessels (pachyvessels) (arrows). G and H. Mid- to late-phase ICGA illustrates multifocal peri-
papillary choroidal hyperpermeability. I and J. OCT through the optic disks of the right (I) and left (J) eyes illustrates intraretinal ﬂuid in both the nasal
and temporal regions adjacent to the optic disks with associated choroidal hypertransmission (arrows) and atrophy of the RPE, ellipsoid zone, and ELM.
Note the peripapillary pachyvessels (asterisks). K and L. Swept-source OCT illustrates intraretinal ﬂuid in the nasal macula and a thickened choroid
(outlined by arrowheads) with pachyvessels (asterisks) more prominent in the nasal versus the temporal areas. Note the presence of subretinal ﬂuid in
both eyes.
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atrophy of RPE, ellipsoid zone, and external limiting
membrane (ELM) with associated choroidal signal
hypertransmission.
Statistical Analysis
Mean choroidal thickness at each position, mean
age, and visual acuity among the three groups were
compared. Snellen visual acuity was converted to
logarithm of the minimum angle of resolution for
statistical analysis. Ratios of nasal to temporal choroi-
dal thickness were calculated and compared. The
differences were tested using Welch test for analysis
of variance with Games–Howell post hoc test for
multiple comparisons. Chi-square or Fischer’s exact
test was used to test differences between proportions.
P value of 0.05 was set as a threshold of signiﬁcance.
Fig. 3. Multimodal imaging of
an 82-year-old man with PPS. A
and B. Fundus autoﬂuorescence
illustrates mottled auto-
ﬂuorescence of the RPE in the
peripapillary region. C and D.
Late-phase FA illustrates peri-
papillary RPE window defects
and mottled ﬂuorescence with-
out focal leakage in each eye.
Note the peripapillary hyper-
ﬂuorescent rings with mild late
leakage in both eyes. E and F.
Early-phase ICGA illustrates
dilated large choroidal vessels
or pachyvessels (arrows) pre-
dominantly in the nasal macula
and peripapillary region in both
eyes. G and H. Mid- to late-
phase ICGA illustrates multifo-
cal choroidal hyperpermeability
in areas corresponding to the
pachyvessels. I and J. Enhanced
depth imaging OCT illustrates
intraretinal ﬂuid with cysts in
the nasal macula extending from
the temporal optic disk margin
and associated with focal RPE,
ellipsoid zone, and ELM atro-
phy (solid arrows) in both eyes.
Note the presence of RPE atro-
phy and the corresponding cho-
roidal signal hypertransmission
(dash arrows) in the peripapil-
lary area in each eye. Note the
thickened nasal macular choroid
(outlined by arrowheads) asso-
ciated with pachyvessels (aster-
isks) and thinning of the
overlying inner choroid. The
pachyvessels are more prom-
inent in the nasal than temporal
sides of the macula, similarly
identiﬁed by ICGA.
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Intraclass correlation coefﬁcients with 95% conﬁdence
intervals were calculated to evaluate intergrader agree-
ment. Statistical analysis was performed using PASW
Statistics for Windows, Version 18.0 (SPSS, Inc,
Chicago, IL).
Results
A total of 31 eyes from 16 patients with peripapil-
lary choroidal thickening associated with intraretinal
and/or subretinal ﬂuid extending from the temporal
disk margin into the macula were identiﬁed (Group 1)
comprising 13 men and 3 women with a mean age of
71 years (SD 7 years, range 58–86 years).
In Group 1, the choroid was thickened preferen-
tially in the nasal macular region in contradistinction
to those eyes with typical PDS and normal eyes as
illustrated in Figures 1–7. Axial length (18 eyes) or
manifest refraction (14 eyes) was available in 20
eyes and nearly all (12 of 14 eyes) were hyperopic
with a mean (±SD) spherical equivalence of +2.5
(±2.2) diopters. Axial lengths ranged from
20.00 mm to 24.59 mm (7 of 18 eyes (39%) had
axial lengths less than 23 mm) with a mean ± SD
of 22.9 ± 1.3 mm. Choroidal folds were present in
24 of 31 (77%) eyes often along the vascular arcades
(Figures 4–6). The optic disk cup was small in most
eyes with 18 of 31 (58%) eyes with a cup less than
0.3 and 10 of 31 (32%) with cupping of 0.1 or with
a crowded disk (Figures 4 and 6). Chronic bilateral
disk edema (Figure 7) was identiﬁed in 2 patients
with normal neurological evaluations that included
unremarkable magnetic resonance imaging of the
brain and orbit and normal lumbar puncture.
Visual acuity in our patients with PPS was relatively
good. Most patients (65%, 20/31 eyes) demonstrated
Fig. 4. A 70-year-old man with
PPS. A and B. Fundus auto-
ﬂuorescence illustrates hypo-
autoﬂuorescent peripapillary
atrophy and mottled auto-
ﬂuorescence at the temporal
disk margin in both eyes with
adjacent hyperautoﬂuorescent
patches. C and D. OCT through
the optic nerve of the right (C)
and left (D) eyes illustrates in-
traretinal ﬂuid extending from
the temporal disk margin. E and
F. Enhanced depth imaging
OCT illustrates intraretinal cysts
in the nasal macula extending
from the disk margin with
associated peripapillary atrophy
with ellipsoid zone and ELM
atrophy (solid arrows). Note the
corresponding choroidal signal
hypertransmission adjacent to
the disk margins (dash arrows).
The choroid is thicker with more
dilated large choroidal vessels
(asterisks) on the nasal side
compared with the temporal side
of the macula (outlined by ar-
rowheads). G and H. OCT B
scans of the right (G) and left
(H) eyes at the level of the green
lines in (A) and (B), respec-
tively, illustrate choroidal folds.
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a visual acuity of 20/30 or better. Anatomical features
associated with reduced visual acuity were intraretinal
cysts approaching the foveal center, subfoveal ﬂuid,
and ellipsoid zone or RPE attenuation at the center of
the fovea. The presence of optic disk edema without
the above anatomical foveal abnormalities did not
correlate with reduced visual acuity. Demographic and
clinical data are summarized in Table 1.
Of the 31 Group 1 eyes, FA was available in 29
eyes, and FAF was available in 25 eyes. Peripapillary
RPE alterations were identiﬁed in all 29 eyes with
corresponding mottled autoﬂuorescence or granular
transmission hyperﬂuorescence on FA without focal
areas of leakage. On FA, all eyes demonstrated late
hyperﬂuorescent staining in a ring-like conﬁguration
immediately surrounding the optic disk with mild
diffuse leakage in 14 eyes (Figure 8) and questionable
mild leakage in another 10 eyes. Hyperautoﬂuorescent
patches in the posterior pole were found in 10 of 25
eyes with FAF assessment (Figures 2, 4, and 6). Grav-
itational tracks of pigmentary abnormalities on either
FA or FAF were illustrated in 8 of 31 eyes (Figures 2
and 6). Indocyanine green angiography was available
in 11 eyes and illustrated peripapillary dilated choroi-
dal vessels with multifocal hyperpermeability in 9 eyes
(Figures 2, 3, and 6).
Fig. 5. Multimodal imaging of
a 69-year-old man with PPS. A
and B. Fundus autoﬂuorescence
illustrates the predominant dis-
tribution of RPE abnormalities
in the peripapillary region of
both eyes. Alternate hyper-
autoﬂuorescent and hypoauto-
ﬂuorescent bands of the
choroidal folds are illustrated in
the left eye (arrows). C and D.
Enhanced depth imaging OCT
illustrates intraretinal cysts in
the nasal macula that extend
from the optic disk margin with
associated atrophy of the RPE,
ellipsoid zone, ELM, and the
corresponding choroidal signal
hypertransmission (arrows).
Note also the presence of small
pigment epithelial detachments
in both eyes and subretinal ﬂuid
in the left eye. The choroid is
thickened with more dilated
large choroidal vessels pre-
dominantly in the nasal and
central macular regions com-
pared with the temporal area in
each eye (outlined by
arrowheads).
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Fig. 6. Multimodal imaging of a 69-year-old man with PPS. A and B. Color fundus photographs illustrate juxtapapillary hard exudates in both eyes,
mild pigmentary changes inferior to disk in the right eye, and a chorioretinal scar temporal to the macula in the left eye. Note the presence of choroidal
folds (arrowheads) in the right eye and a small cup-to-disk ratio in both eyes. C and D. Fundus autoﬂuorescence illustrates mild mottled auto-
ﬂuorescence temporal to the right disk and inferior to the left disk. A hyperautoﬂuorescent patch superior to the disk and mottled autoﬂuorescence
inferior to the disk in a gravitational pattern are illustrated in the right eye. There are hyperautoﬂuorescent patches inferonasal to the disk, superior to the
fovea, and concentric to the hypoautoﬂuorescent scar in the left eye. E and F. FA illustrates multiple foci of window defects with late staining in the
macula and peripapillary region, and multiple small pigment epithelial detachments in the right eye with a speckled hyperﬂuorescent gravitational tract
extending from the disk inferiorly in the right eye. A hypoﬂuorescent scar with late staining and variable staining in the peripapillary region are noted in
the left eye. No signiﬁcant ﬂuorescein leakage is identiﬁed in either eye. Note the alternate hyperﬂuorescent and hypoﬂuorescent bands of choroidal
folds superotemporally in the right eye greater than the left eye (arrowheads). G–J. Indocyanine green angiography. Early ICGA (G and I) illustrates
dilated large choroidal vessels in the peripapillary region and central macula with corresponding multifocal hyperpermeability in the midphase ICGA (H
and J) in both eyes. K and L. Enhanced depth imaging OCT illustrates intraretinal ﬂuid in the nasal macula extending from the disk margins with
associated atrophy of the RPE, ellipsoid zone, ELM, and the corresponding choroidal signal hypertransmission (arrows) in both eyes. A temporal
chorioretinal scar with surrounding intraretinal cysts and subfoveal ﬂuid are also illustrated in the left eye. Note the thickened choroid (outlined by
arrowheads) and dilated large choroidal vessels predominantly within the nasal region of each eye.
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In addition to choroidal hyperpermeability, most
eyes (19/27, 70%) exhibited other features of the PDS
including serous pigment epithelial detachment (13/
31, 42%), FAF evidence of previous serous retinal
detachment outside the peripapillary region (15/25,
60%), and a gravitational track of RPE alteration (8/
31, 26%) (Figures 2 and 6).
Retinal structures at disk margins were studied by
OCT. All eyes illustrated intraretinal ﬂuid and cysts
extending from the temporal disk margin with associ-
ated atropy of the RPE, ellipsoid zone, and ELM
(Figures 2–7). These atrophic areas of the RPE and
outer retina resulted in choroidal signal hypertransmis-
sion at the optic disk margin in all eyes. Varying
amounts of subretinal ﬂuid were present in 23 of 31
eyes. Optical coherence tomography B scans through
the optic disks were available in 18 eyes, 11 of which
demonstrated intraretinal ﬂuid at the nasal disk margin
(Figures 2 and 7).
To more accurately assess the signiﬁcance of the
choroidal thickness of the 31 eyes in Group 1,
comparative control groups were recruited to the
study. Group 2 comprised 17 eyes from 11 patients
and included eyes with typical CSC (13 eyes from 8
patients) or eyes with pachychoroid neovasculopathy
(4 eyes from 3 patients). Group 3 comprised 19 normal
eyes from 12 age-matched controls. The mean age was
not statistically different between the 3 groups (P =
0.117), but there were more women in Group 3 (Table
2). There was an excellent agreement in choroidal
thickness measurements between the two readers with
an intraclass correlation coefﬁcient of 0.996 (95% con-
ﬁdence interval, 0.995–0.997).
Analysis of choroidal thickness demonstrated sig-
niﬁcant differences among the three groups (Figure 9).
The mean choroidal thickness in Group 1 (PPS) and
Group 2 (typical PDS) was signiﬁcantly greater than
Group 3 (normal) at all 6 measured positions (P ,
0.01) except for position T3.0, where the difference
between Group 1 and Group 3 was not statistically
different (P = 0.06). Interestingly, Groups 1 and 2
illustrated different choroidal thickness proﬁles. Mean
Fig. 7. Multimodal imaging of
a 71-year-old man with PPS
and chronic bilateral optic disk
edema for over 1 year. The
patient initially presented with
bilateral enlarged blind spots and
meticulous neurological workup
including magnetic resonance
imaging of the brain and orbits,
lumbar puncture and cerebrospi-
nal ﬂuid analysis and infectious
serology were all negative. A and
B. Enhanced depth imaging OCT
illustrates intraretinal ﬂuid in the
nasal macula extending from the
optic disk margin in each eye and
subretinal ﬂuid in the left eye.
Atrophy of the RPE, ellipsoid
zone, and ELM is noted at the
temporal disk margins and asso-
ciated with corresponding cho-
roidal signal hypertransmission
(arrows). The choroid is thick
with dilated large choroidal ves-
sels more prominent in the nasal
versus the temporal side in both
eyes (outlined by arrowheads). C
and D. OCT through the optic
nerve head illustrates the pres-
ence of disk edema and intra-
retinal cysts surrounding the
optic disk.
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Table 1. Demographic and Clinical Data of Patients With PPS
Patient
Age,
years Sex Eye VA
Axial
Length, mm
Spherical
Equivalence
Choroidal
Folds
Cup-to-Disk
Ratio Underlying Diseases
1 65 F OD 20/50 23.8 +6.50 Present 0.4 Monoclonal
gammopathy of
uncertain signiﬁcance,
Raynaud disease,
Chiari I malformation
OS 20/30 23.7 +5.75 Present 0.4
2 86 F OD 20/30 21.9 NA Present 0.2 Hypertension,
hypercholesterol, sick
sinus syndrome,
breast cancer status
post mastectomy and
radiation
OS 20/60 21.8 NA Present 0.3
3 75 M OD 20/40 23.7 +2.00 Present 0.2 Hypertension, sleep
apneaOS 20/25 23.5 +2.00 Present 0.3
4 71 M OD 20/20 23.1 +3.75 Present 0.1, edema Hyperlipidemia, prostrate
cancer (inactive),
transient ischemic
attack, anxiety
OS 20/40 22.8 +4.125 Present 0.1, edema
5 69 M OD 20/25 23.6 20.75 Present 0.2 Diabetes mellitus Type 2
OS 20/25 23.8 20.75 Present 0.3
6 70 M OD 20/50 22.6 +2.00 Present 0.2, edema Multiple myeloma
OS 20/25 22.1 +2.50 Present 0.3, edema
7 79 M OD 20/20 24.6 NA Absent 0.3 None
OS 20/30 24.4 NA Absent 0.3
8 73 F OD 20/25 NA NA Present 0.1 Hypertension, melanoma
of the foot and leg,
Raynaud disease,
osteoarthritis,
osteopenia
OS 20/40 NA NA Present 0.1
9 63 M OD 20/40 20.0 NA Present 0.3 Hypertension
OS 20/120 20.0 NA Present 0.3
10 67 M OD 20/25 NA +4.50 Present 0.4 Kidney failure with renal
artery stenosis,
noninvasive bladder
tumors
OS 20/30 NA NA Present 0.4
11 73 M OD 20/20 NA NA Absent 0.1 End-stage renal disease
status post kidney
transplantation,
coronary artery
disease, diabetes
mellitus, hypertension,
hyperlipidemia
OS 20/60 NA NA Absent 0.1
12 75 M OD 20/25 NA NA Present 0.1 Diabetes mellitus,
hypertension,
hyperlipidemia, sleep
apnea, coronary artery
disease, anemia,
pancreatic cyst,
chronic renal
insufﬁciency
OS 20/30 NA NA Present 0.1
13 70 M OD 20/80 23.8 +1.25 Present 0.1 Hypertension,
hyperlipidemiaOS 20/25 23.9 +0.50 Present 0.1
14 82 M OD 20/25 NA NA Present 0.25 Chronic kidney disease,
polymyalgia
rheumatica (on
prednisolone)
OS 20/25 NA NA Present 0.2
15 65 M OD 20/250 NA NA Absent 0.2 Diabetes mellitus Type 2
OS 20/30 NA NA Absent 0.3
16 58 M OD 20/25 NA +2.00 Absent 0.2 None
NA, not available.
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subfoveal choroidal thickness was not statistically dif-
ferent between these 2 groups; however, the mean
choroidal thickness in the nasal macula in Group 1
was signiﬁcantly greater than that of Group 2 at posi-
tions N1.5 and N3.0 (P = 0.038 and 0.006, respec-
tively). The choroidal thickness of Group 1 then
decreased sharply from the center position toward
the temporal macula and was thinner than Group 2
temporally. In Group 1, the temporal macular choroid
was even thinner than the nasal side. By contrast, the
temporal macular choroid of Group 2 remained rela-
tively thicker than the nasal side, demonstrating the
same pattern as Group 3 (normal).
As the choroidal thickness was evidently thick-
ened in the peripapillary region in Group 1, we
performed an additional analysis of the ratio of nasal
to temporal choroidal thickness. The ratios of
choroidal thickness at N3.0 to T3.0 were 1.33 ±
0.60, 0.64 ± 0.18, and 0.49 ± 0.17 for Groups 1,
2, and 3, respectively. The ratios of choroidal thick-
ness at BMO250 to T3.0 were 0.65 ± 0.23, 0.35 ±
0.13, and 0.31 ± 0.14 for Groups 1, 2, and 3, respec-
tively. Furthermore, the ratios of the sum of choroi-
dal thickness at N1.5 and N3.0 to the sum of that at
T1.5 and T3.0 were 1.36 ± 0.43, 0.80 ± 0.18, and
0.65 ± 0.20 for Groups 1, 2, and 3, respectively. The
differences between all these ratios of Group 1 ver-
sus Group 2 were all statistically signiﬁcant (P ,
0.00001). Figure 10 demonstrates the distribution of
eyes with various ratios of nasal to temporal choroi-
dal thickness. Group 1 was considerably different
from Groups 2 to 3. There were no eyes with an
N3.0/T3.0 ratio greater than 1 in Groups 2 and 3,
whereas 23/31 (74%) of eyes in Group 1 had an
N3.0/T3.0 ratio greater than 1 (P , 1027).
Data regarding treatment response were available
for some study eyes. Three eyes treated with intra-
vitreal anti–vascular endothelial growth factor
therapy illustrated no response. One eye had reso-
lution of macular ﬂuid after verteporﬁn photody-
namic therapy, whereas two other eyes showed no
response. Two eyes treated with topical dorzolamide
had resolution of macular ﬂuid, whereas one eye
showed minimal improvement. Oral acetazolamide
in one patient was not associated with a reduction in
macular ﬂuid. One eye had spontaneous resolution
of ﬂuid with observation.
Discussion
We studied eyes with peripapillary choroidal thick-
ening associated with intraretinal and/or subretinal
ﬂuid extending from the temporal disk margin into the
macula. Our analysis demonstrated that the nasal
macular choroid was signiﬁcantly thicker than the
temporal macular choroid in these eyes (Group 1),
especially when compared with normal or typical PDS
eyes. Most PPS eyes demonstrated choroidal folds (24/
31, 77%), a relatively short axial length (7 of 18 eyes
[39%] with axial lengths less than 23 mm) and
a hyperopic refractive error (12/14, 86%). Many eyes
(11/18, 61%) with available OCT B scans through the
optic disk also illustrated intraretinal ﬂuid on the nasal
side of the nerve. The optic disk of these patients was
typically crowded, and a small cup was identiﬁed in
more than half of the cases with optic disk edema
noted in four eyes of two cases. This unique clinical
presentation prompted us to coin the term “peripapil-
lary pachychoroid syndrome.” The ﬁndings of PPS
were bilateral in 15 of our 16 cases.
Our analysis illustrated that the pattern of choroidal
thickness in our PPS eyes was signiﬁcantly (P ,
0.0001) different than that of typical PDS entities such
as CSC and pachychroid neovasculopathy and normal
controls. Studies have illustrated that the macular cho-
roidal thickness is normally greatest in the subfoveal
position followed by the temporal and nasal posi-
tions.9,10 This was remarkably different from the pat-
tern identiﬁed in PPS eyes, in which the nasal macular
choroid was disproportionately thicker with associated
pachyvessels compared with normal or typical PDS
eyes and often thicker than the temporal macular cho-
roid of the same eye (Figures 1, 9, and 10). Peripapil-
lary choroidal thickening was associated with
peripapillary RPE mottling on FAF or FA in all cases,
but FA did not show focal leakage. Mild optic disk
leakage was observed in 14/29 (48%) eyes without
evidence of ocular inﬂammation (Figure 8). Indocya-
nine green angiography demonstrated dilated peripa-
pillary large choroidal vessels with multifocal
choroidal hyperpermeability identiﬁed in the midphase
ICGA.
The association of PPS with choroidal folds, short
axial length, and hyperopia indicated similarities
with UES, although there was no evidence of serous
choroidal detachment in any of our cases. Recent
case reports,6,11 with very similar ﬁndings to our
cases of PPS, have applied the term “isolated poste-
rior uveal effusion” to describe a syndrome charac-
terized by a thick posterior choroid with serous
macular detachment, nasal cystoid macular edema,
choroidal folds, and short axial length without
peripheral retinochoroidal detachment. However,
we believe that our cases illustrated more in com-
mon with PDS rather than a form of UES for the
following reasons: 1) Our patients often displayed
serous RPE detachment and gravitational tracks of
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RPE alteration, which are commonly seen in PDS
and have not been described in UES. In addition,
pigmentary changes in a leopard-spot pattern char-
acteristic of UES were not identiﬁed in our patients;
2) ICGA in our patients was very characteristic for
PDS and included typical ﬁndings such as dilated
large choroidal veins (pachyvessels) and choroidal
hyperpermeability.1,4,12,13 The pachyvessels were
identiﬁed during dye transit and washed out in the
late phase of the study. These pachyvessels corre-
sponded to dilated Haller layer vessels visible on
structural EDI-OCT and typically illustrated attenuation
of the overlying Sattler layer and choriocapillaris.
Indocyanine green angiography hyperpermeability was
typically focal or multifocal, best seen during the
midphase of the study, and often was observed around
the washed out silhouettes of the pachyvessels. This
hyperpermeability often faded in the late phase of the
ICGA. By contrast, Uyama et al14 reported the ICGA
pattern in UES as a diffusely granular hyperﬂuorescence
in the very early phase, which increased with time and
persisted until the late phase of the study as a diffuse
intense choroidal hyperﬂuorescence; 3) The location of
abnormal ﬁndings predominantly around the optic nerve
and in the nasal macula was not consistent with UES and
was much more typical of PDS/CSC. Hence, we prefer
the term “peripapillary pachychoroid syndrome” for this
entity. We have reﬁned the clinical picture demonstrating
that, unlike most other PDS disorders, the choroid in PPS
is preferentially thickened in the nasal macula compared
with the temporal macula. It is believed that the primary
abnormality of the pachychoroid spectrum disorders
relates to dilated choroidal vessels,3–5 whereas in UES,
a reduced ﬂuid and protein permeability of the sclera is
the main mechanism.14,15 It is possible that reduced
scleral permeability with older age16,17 may exacerbate
peripapillary choroidal congestion in patients with PPS,
giving rise to some overlapping ﬁndings with UES.
A recent large case series of patients with chorior-
etinal folds caused by various ocular disorders
included eyes with mottled hyperﬂuorescence in the
peripapillary and/or macular regions similar to our
cases.18 However, EDI-OCT and choroidal imaging
were not performed in these eyes. According to the
ﬁndings of our study, PPS should also be considered
in the differential diagnosis of chorioretinal folds.
Although certain ﬁndings in PPS eyes were sugges-
tive of chronic CSC, another PDS entity, there were
important distinguishing features. Overlapping ﬁnd-
ings included serous pigment epithelial detachment,
gravitational tracks, evidence of serous retinal detach-
ment outside the peripapillary region with FAF, and
outer retinal atrophy in most (19/27, 70%) PPS eyes
(Figures 2 and 6). Also, a male predilection (13/16,
81%) and the ICGA ﬁndings of pachyvessels and hy-
perpermeability were similar to that of CSC. The most
important feature distinguishing PPS from CSC was
the preferential choroidal thickening in the peripapil-
lary region as demonstrated in Figures 1, 9, and 10.
The choroidal thickness proﬁle was signiﬁcantly dif-
ferent from typical CSC in that the nasal macular cho-
roid was thickened and the thickness sharply
decreased toward the temporal side. Other useful dis-
tinguishing features included the presence of choroidal
Fig. 8. Late FA illustrates peripapillary hyperﬂuorescent rings with mild late leakage in right and left eyes of 4 cases with PPS.
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folds, older age, and a small cup-to-disk ratio with
mild disk leakage with late FA, not commonly present
in CSC.
Multimodal imaging analysis in our study suggested
that the primary abnormality of PPS resided in the
peripapillary choroid where the characteristic PDS
ﬁndings of ICGA hyperpermeability and pachyvessels
were observed. Peripapillary choroidal congestion in
PPS may lead to high hydrostatic pressure under the
RPE causing RPE dysfunction and leakage of ﬂuid
into the subretinal space as has been postulated in the
context of CSC.14,19 This hydrostatic pressure may be
subject to a compartment-like syndrome (if choroidal
outﬂow is disrupted) and may compress the optic
nerve leading to complications including crowded
disk, optic disk edema, and/or optic disk leakage.
Growing evidence of peripapillary pachychoroid ex-
erting pressure stress on the optic nerve has recently
emerged as a contributing factor for acquired lamina
cribrosa defects20 and nonarteritic anterior ischemic
optic neuropathy.21 The reason why the choroid is
congested preferentially in the peripapillary region is
unclear. Interestingly, choroidal venous drainage from
the peripapillary choroidal region has been studied
histologically.22 These veins penetrate the sclera
around the optic nerve and enter the pia mater of the
nerve and are called choroidopial veins. Whether there
is an increased resistance of choroidal venous outﬂow
through these choroidopial veins or the vortex veins in
PPS requires further investigation.
The mechanism of intraretinal ﬂuid extension from
the disk margin in PPS is unclear. Fluorescein leakage
Table 2. Demographic and Visual Acuity Data of the Three Groups of Subjects in This Study
Group 1 (PPS) Group 2 (PDS) Group 3 (Normal) P
Age, years
Mean ± SD 71.3 ± 7.2 63.7 ± 9.7 69.3 ± 5.7
Range 58–86 52–80 61–79 0.1170
Sex, male/female, %male 13/3, 81 9/2, 82 4/8, 33 0.0180
LogMAR VA, mean ± SD 0.2 ± 0.2 0.3 ± 0.5 0.0 ± 0.1 0.0004
Mean Snellen VA 20/32 20/40 20/20
LogMAR, logarithm of the minimum angle of resolution.
Fig. 9. This graph illustrates
choroidal thickness at different
positions in the macula of eyes
with PPS. A distinctive choroi-
dal thickness proﬁle is noted.
The nasal choroid is signiﬁ-
cantly thicker and sharply thins
out toward the temporal side in
the group of eyes with PPS
versus the normal and the typi-
cal PDS groups. Group 1, PPS;
Group 2, typical PDS (CSC or
pachychoroid neovasculopathy);
Group 3, age-matched normal
eyes; BMO250, 250 mm tem-
poral to Bruch membrane ori-
gin; N3.0, 3,000 mm nasal to the
foveal center; N1.5, 1,500 mm
nasal to the foveal center; SF,
subfoveal; T1.5, 1,500 mm
temporal to the foveal center;
and T3.0, 3,000 mm temporal to
the foveal center. P values were
signiﬁcant when the designated
intervals were compared, *P ,
0.05 and **P , 0.01.
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was minimal in PPS eyes and angiographic cystoid
macular edema was not appreciated in these cases. It
has been suggested that intraretinal cystic ﬂuid may
originate from the congested choroid through regions
of peripapillary atrophy and associated atrophy of the
RPE and ELM that normally serve as barriers for ﬂuid
to enter the retina.6 In this study, atrophy of the RPE
and ELM and the corresponding choroidal signal hy-
pertransmission at the temporal disk margins were de-
tected by spectral domain OCT in all cases even in
cases without frank peripapillary atrophy, and these
juxtapapillary atrophic areas may facilitate ﬂuid entry
into the retina. Whether these atrophic areas are second-
ary to chronic hydrostatic stress to the optic disk margin
from the congested peripapillary choroid or secondary
to the presence of chronic subretinal ﬂuid because of
RPE dysfunction requires further longitudinal investi-
gation. Alternatively, the intraretinal cysts without FA
leakage may represent degenerative cavitation as has
been described in the context of chronic CSC,23–25
although the presence of SRF and large exudative-like
retinal cysts in many cases makes cavitation unlikely.
A recent study by Lee et al20 described the presence
of lamina cribrosa defects or disinsertions as a potential
source of intraretinal ﬂuid extending from the disk
without leakage on FA in patients with pachychoroid
disorders and patients with glaucomatous optic neu-
ropathy. This study has proposed that a thickened cho-
roid could stress the optic nerve head margin and lead
to a lamina cribrosa defect or disinsertion and subse-
quent intraretinal ﬂuid. Our study was retrospective
and did not use an EDI-OCT raster protocol with suf-
ﬁcient density to detect such defects. Of note, the pa-
chychoroid subjects in Lee’s study seemed to be
different from ours because Lee’s study excluded eyes
with peripapillary intraretinal ﬂuid associated with
RPE atrophy (peripapillary ﬂuid and RPE atrophy
were found in all cases in our study), and only two
of eight eyes illustrated late staining of the optic nerve
border (as opposed to all eyes in our study). Also, it
was not clear in their study whether the macular cho-
roid was preferentially thickened nasally as in PPS.
Furthermore, the lamina cribrosa defects were not de-
tected in about half of their pachychoroid patients.
This indicates that there may be more than one mech-
anism of intraretinal ﬂuid accumulation.
The association of a crowded disk appearance or
optic disk edema with PPS is interesting. Sarraf and
Schwartz,26 before the OCT era, described three cases
of bilateral choroidal folds and short axial length asso-
ciated with crowded disk and FA leakage in one eye
and optic atrophy in the fellow eye. They excluded
neurological disorders including idiopathic intracranial
hypertension and proposed that idiopathic acquired
Fig. 10. Histograms illustrating distributions of different ratios of nasal
to temporal choroidal thickness in each group. A. Ratio of choroidal
thickness: BMO250 over T3.0. B. Ratio of choroidal thickness: N3.0
over T3.0. C. Ratio of nasal to temporal choroidal thickness (N/T =
[N1.5 + N3.0]/[T1.5 + T3.0]). The distribution of nasal to temporal
choroidal thickness ratios illustrates a shift toward a value of 1 or
greater for Group 1 (unlike Groups 2 and 3) indicating that the nasal
choroid is thicker than the temporal choroid in contrast with Groups 2
and 3. P values indicate comparisons of the mean ratios between each
group. The differences between Group 1 versus Group 2 and Group 1
versus Group 3 were highly statistically signiﬁcant. Group 1, PPS;
Group 2, typical PDS (CSC or pachychoroid neovasculopathy); Group
3, age-matched normal eyes; BMO250, 250 mm temporal to Bruch
membrane origin; N3.0, 3,000 mm nasal to the foveal center; N1.5,
1,500 mm nasal to the foveal center; T1.5, 1,500 mm temporal to the
foveal center; T3.0, 3,000 mm temporal to the foveal center.
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hyperopia and shrinkage of the scleral canal could lead
to a crowded disk syndrome and the development of
nonarteritic anterior ischemic optic neuropathy. Some
of our cases shared similar features of small optic
cups, optic disk leakage, short axial lengths, and cho-
roidal folds. These ﬁndings were similar to the
crowded disk syndrome cases described by Sarraf
and Schwartz,26 and it is possible that these cases
would have demonstrated PPS with current multi-
modal imaging capabilities. As mentioned above,
a ﬁnding of peripapillary pachychoroid has recently
been implicated in nonarteritic anterior ischemic optic
neuropathy.21 Whether patients with PPS have a higher
incidence of nonarteritic anterior ischemic optic neu-
ropathy requires further investigation, however.
It should be acknowledged that some eyes in our
study could be classiﬁed with more than one PDS
disorder (hence the term “spectrum”). Peripapillary
pachychoroid syndrome is best deﬁned by the pres-
ence of characteristic peripapillary abnormalities. In
some eyes, this may be the primary pathology, but
in others, these ﬁndings may be more of an incidental
ﬁnding detected during an evaluation of some other
disorders of the PDS such as CSC or polypoidal cho-
roidal vasculopathy. In this study, eyes with Type 1
neovascularization were excluded from Group 1 anal-
ysis. However, PPS may be associated with Type 1
neovascularization with or without polyps.
Limitations of this analysis included the retrospec-
tive nature of the study, incomplete data collection and
incomplete multimodal imaging in some cases, and the
relatively small sample size. Choroidal analysis was
compared with control eyes using a single-line EDI-
OCT scan through the foveal center. Future pro-
spective and longitudinal studies with comparative
volumetric OCT scans would be valuable to corrob-
orate our ﬁndings.
In summary, we have described a new subgroup in
the PDS referred to as PPS and characterized by
a relatively thickened nasal macular choroid (vs. the
temporal choroid) with associated intraretinal and
subretinal ﬂuids in the nasal macular region extending
from the disk margin. Intraretinal and subretinal ﬂuids
can also be identiﬁed nasal to the optic disk. Focal
RPE and ELM atrophy at the disk margin and
corresponding choroidal hypertransmission were iden-
tiﬁed in all eyes and may indicate the site of ﬂuid entry
into the retina. Fundus autoﬂuorescence and FA
illustrated peripapillary mottling of the RPE with late
staining but minimal or no leakage. Indocyanine green
angiography demonstrated pachyvessels and multifo-
cal hyperpermeability in the peripapillary region. The
optic nerve head was usually crowded with mild late
leakage with FA and even edematous in certain cases.
Patients with PPS were mostly men but typically older
than those with CSC. Choroidal folds, a relatively
short axial length and hyperopia were common
associations. Peripapillary choroidal congestion with
a compartment-like effect on the peripapillary region
was proposed as an etiologic mechanism. Although
PPS may be considered in the spectrum of pachych-
oroid disorders such as CSC, the aggregate of
presenting features are sufﬁciently characteristic as to
be considered a unique syndrome. It is important to
recognize PPS and distinguish this new clinical entity
from similar disorders such as posterior uveitis and
neuro-ophthalmologic conditions that can share over-
lapping features, namely disk leakage and edema.
Key words: central serous chorioretinopathy, cho-
roidal folds, choroidal thickness, optic disk edema,
pachychoroid disease spectrum.
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